Impact of Gene Mutations on Survival with Azacitidine or Conventional Care Regimens (CCR) in Older Patients with Acute Myeloid Leukemia
Tang, L, Dolnik, A, MacBeth, K.J, Dombret, H, Seymour, J.F, Minden, M.D, Stone, R.M, Beach, C.L, Döhner, H, Bullinger, L
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Impact of Gene Mutations on Response to Lenalidomide and OS in Lower-Risk Non-Del(5Q) MDS Patients Ineligible/Refractory to Erythropoiesis-Stimulating Agents (ESAS)
Santini, V, Fenaux, P, Giagounidis, A, Platzbecker, U, Almeida, A, List, A.F, Zhong, J, Wu, C, Mavrommatis, K, Beach, C.L, MacBeth, K.J
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)
Santini, V, Almeida, A, Giagounidis, A, Gröpper, S, Jonasova, A, Vey, N, Mufti, G.J, Buckstein, R, Mittelman, M, Platzbecker, U, Shpilberg, O, Ram, R, del Canizo, C, Gattermann, N, Ozawa, K, Risueno, A, MacBeth, K.J, Zhong, J, Séguy, F, Hoenekopp, A, Beach, C.L, Fenaux, P
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
181 Oral azacitidine is bioavailable and reduces DNA methylation at low doses in extended schedules: Phase I study results
Laille, E, Shi, T, Garcia-Manero, G, Gore, S.D, Cogle, C.R, Giordano, H, MacBeth, K.J, Skikne, B
Published in Leukemia research (01.05.2011)
Published in Leukemia research (01.05.2011)
Get full text
Journal Article
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes
Garcia-Manero, G, Gore, S D, Kambhampati, S, Scott, B, Tefferi, A, Cogle, C R, Edenfield, W J, Hetzer, J, Kumar, K, Laille, E, Shi, T, MacBeth, K J, Skikne, B
Published in Leukemia (01.04.2016)
Published in Leukemia (01.04.2016)
Get full text
Journal Article
110 - Impact of Gene Mutations on Survival with Azacitidine or Conventional Care Regimens (CCR) in Older Patients with Acute Myeloid Leukemia
Tang, L., Dolnik, A., MacBeth, K.J., Dombret, H., Seymour, J.F., Minden, M.D., Stone, R.M., Beach, C.L., Döhner, H., Bullinger, L.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
24 - Impact of Gene Mutations on Response to Lenalidomide and OS in Lower-Risk Non-Del(5Q) MDS Patients Ineligible/Refractory to Erythropoiesis-Stimulating Agents (ESAS)
Santini, V., Fenaux, P., Giagounidis, A., Platzbecker, U., Almeida, A., List, A.F., Zhong, J., Wu, C., Mavrommatis, K., Beach, C.L., MacBeth, K.J.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article